Formac Pharmaceuticals has developed a significant technological advancement in drug delivery through its exclusive licensing of Ordered Mesoporous Silica patents. This innovative technology allows for the creation of highly ordered porous structures that can encapsulate and release pharmaceutical compounds in a controlled manner. The use of Ordered Mesoporous Silica enhances the bioavailability and efficacy of drugs, making it a promising solution for improving therapeutic outcomes in various medical applications.

In addition to its focus on drug delivery systems, Formac Pharmaceuticals emphasizes the importance of scientific research and development in its operations. The company is committed to advancing pharmaceutical technologies that can lead to more effective treatments. By leveraging cutting-edge materials and methodologies, Formac aims to contribute to the evolving landscape of drug formulation and delivery, ultimately enhancing patient care and treatment options.

Belgium

Formac Pharma is a pharmaceutical company that specializes in developing best in class new pharmaceutical products using silica-based drug delivery platforms to improve the performance of poorly soluble compounds, while also partnering with pharmaceutical and animal health companies.

Formac Pharmaceuticals

Company Details